0000-0002-6715-6005 Employment
Employment history is unavailable.
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (176)
- Wnt antagonist as therapeutic targets in ovarian cancer Save
- Molecular dysregulations underlying the pathogenesis of endometriosis Save
- Netrin-like domain of sFRP4, a Wnt antagonist inhibits stemness, metastatic and invasive properties by specifically blocking MMP-2 in cancer stem cells from human glioma cell line U87MG Save
- Microvascular cells: A special focus on heterogeneity of pericytes in diabetes associated complications Save
- Inhibition of breast cancer stem-like cells by a triterpenoid, ursolic acid, via activation of Wnt antagonist, sFRP4 and suppression of miRNA-499a-5p Save
- Computational screening of dual inhibitors from FDA approved antiviral drugs on SARS-CoV-2 spike protein and the main protease using molecular docking approach Save
- Role of histone acetyltransferase inhibitors in cancer therapy Save
- Comprehensive review on the prevailing COVID-19 therapeutics and the potential of repurposing SARS-CoV-1 candidate drugs to target SARS-CoV-2 as a fast-track treatment and prevention option Save
- Aberrant lipid metabolism as an emerging therapeutic strategy to target cancer stem cells Save
- Pigment epithelium-derived factor regulation of neuronal and stem cell fate Save